I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,259,250,000 | – | 15,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
| Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
| IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
| Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
| EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
| HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
| Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
| Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |